$36.6 Million is the total value of SVB FINANCIAL GROUP's 30 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| COIN | New | COINBASE GLOBAL INC | $14,402,774 | – | 406,973 | +100.0% | 39.37% | – |
| OKTA | New | OKTA INCcl a | $7,653,780 | – | 112,012 | +100.0% | 20.92% | – |
| New | ROOT INCcl a | $3,515,724 | – | 783,012 | +100.0% | 9.61% | – | |
| AXSM | New | AXSOME THERAPEUTICS INC | $2,610,773 | – | 33,849 | +100.0% | 7.14% | – |
| FROG | New | JFROG LTD | $1,603,974 | – | 75,198 | +100.0% | 4.38% | – |
| New | DICE THERAPEUTICS INC | $1,321,570 | – | 42,358 | +100.0% | 3.61% | – | |
| CMAX | New | CAREMAX INC | $1,095,000 | – | 300,000 | +100.0% | 2.99% | – |
| New | PLANET LABS PBC | $748,622 | – | 172,097 | +100.0% | 2.05% | – | |
| New | OWLET INC | $492,823 | – | 881,458 | +100.0% | 1.35% | – | |
| New | ROVER GROUP INC | $387,310 | – | 105,534 | +100.0% | 1.06% | – | |
| New | NOGIN INC | $326,793 | – | 424,406 | +100.0% | 0.89% | – | |
| New | CARIBOU BIOSCIENCES INC | $295,480 | – | 47,051 | +100.0% | 0.81% | – | |
| CGEM | New | CULLINAN ONCOLOGY INC | $285,188 | – | 27,032 | +100.0% | 0.78% | – |
| KROS | New | KEROS THERAPEUTICS INC | $223,437 | – | 4,653 | +100.0% | 0.61% | – |
| ALVR | New | ALLOVIR INC | $220,687 | – | 43,019 | +100.0% | 0.60% | – |
| GBIO | New | GENERATION BIO CO | $207,976 | – | 52,920 | +100.0% | 0.57% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $169,816 | – | 16,173 | +100.0% | 0.46% | – | |
| KNTE | New | KINNATE BIOPHARMA INC | $142,630 | – | 23,382 | +100.0% | 0.39% | – |
| SKLZ | New | SKILLZ INC | $138,749 | – | 273,936 | +100.0% | 0.38% | – |
| New | SELINA HOSPITALITY PLC | $136,088 | – | 50,217 | +100.0% | 0.37% | – | |
| New | PARDES BIOSCIENCES INC | $131,880 | – | 77,880 | +100.0% | 0.36% | – | |
| New | WAG GROUP CO | $130,167 | – | 42,262 | +100.0% | 0.36% | – | |
| ELDN | New | ELEDON PHARMACEUTICALS INC | $93,054 | – | 40,613 | +100.0% | 0.25% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $83,837 | – | 10,249 | +100.0% | 0.23% | – |
| VERO | New | VENUS CONCEPT INC | $51,200 | – | 160,000 | +100.0% | 0.14% | – |
| New | MONEYLION INCcl a | $46,235 | – | 74,573 | +100.0% | 0.13% | – | |
| FULC | New | FULCRUM THERAPEUTICS INC | $22,422 | – | 22,422 | +100.0% | 0.06% | – |
| New | GREENLIGHT BIOSCIENCES HLDS P | $20,001 | – | 16,950 | +100.0% | 0.06% | – | |
| New | TEMPO AUTOMATION HOLDINGS IN | $16,282 | – | 20,813 | +100.0% | 0.04% | – | |
| New | GROVE COLLAB HOLD INC | $11,699 | – | 29,320 | +100.0% | 0.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COINBASE GLOBAL INC | 4 | Q3 2023 | 57.5% |
| OKTA INC | 4 | Q3 2023 | 20.9% |
| ROOT INC | 4 | Q3 2023 | 14.0% |
| AXSOME THERAPEUTICS INC | 4 | Q3 2023 | 7.1% |
| CAREMAX INC | 4 | Q3 2023 | 3.0% |
| PLANET LABS PBC | 4 | Q3 2023 | 2.0% |
| MOONLAKE IMMUNOTHERAPEUTICS | 4 | Q3 2023 | 1.7% |
| ROVER GROUP INC | 4 | Q3 2023 | 1.2% |
| CULLINAN ONCOLOGY INC | 4 | Q3 2023 | 0.8% |
| CARIBOU BIOSCIENCES INC | 4 | Q3 2023 | 0.8% |
View SVB FINANCIAL GROUP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | February 10, 2023 | 1,716,764 | 8.8% |
| Root, Inc. | February 10, 2023 | 783,012 | 8.6% |
| BigCommerce Holdings, Inc. | February 12, 2021 | 392,224 | 0.6% |
| ISC8 INC. /DE | February 17, 2015 | 34,533,213 | 11.9% |
View SVB FINANCIAL GROUP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 8-K | 2024-03-22 |
| 8-K | 2024-03-20 |
| 8-K | 2024-02-26 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 8-K | 2024-02-09 |
| 8-K | 2024-02-01 |
| 8-K | 2024-01-29 |
| SC 13G/A | 2024-01-17 |
| 8-K | 2024-01-10 |
View SVB FINANCIAL GROUP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.